EDGAR Filing Documents for 0001104659-18-065143

Form 8-K - Current report:

SEC Accession No. 0001104659-18-065143

Filing Date

2018-10-31

Accepted

2018-10-31 17:08:49

Documents

Period of Report

2018-10-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a18-39298_18k.htm	8-K	49849
2	EX-2.1	a18-39298_1ex2d1.htm	EX-2.1	445361
3	EX-2.2	a18-39298_1ex2d2.htm	EX-2.2	550742
4	EX-99.1	a18-39298_1ex99d1.htm	EX-99.1	25595
5	GRAPHIC	g392981mmi001.jpg	GRAPHIC	3085
	Complete submission text file	0001104659-18-065143.txt		1077211

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 181151084
SIC: 2834 Pharmaceutical Preparations